Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20452314rdf:typepubmed:Citationlld:pubmed
pubmed-article:20452314lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:20452314lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:20452314lifeskim:mentionsumls-concept:C0039538lld:lifeskim
pubmed-article:20452314lifeskim:mentionsumls-concept:C1510438lld:lifeskim
pubmed-article:20452314lifeskim:mentionsumls-concept:C1514185lld:lifeskim
pubmed-article:20452314pubmed:issue5lld:pubmed
pubmed-article:20452314pubmed:dateCreated2010-5-10lld:pubmed
pubmed-article:20452314pubmed:abstractTextThe teratoma assay is the gold standard for documenting pluripotency of human stem cells. However, reports of new human ESC and iPSC lines vary widely in both methods and analysis of teratoma data. We call for consensus standards to be established to make this assay worthy of its "golden" status.lld:pubmed
pubmed-article:20452314pubmed:languageenglld:pubmed
pubmed-article:20452314pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20452314pubmed:citationSubsetIMlld:pubmed
pubmed-article:20452314pubmed:statusMEDLINElld:pubmed
pubmed-article:20452314pubmed:monthMaylld:pubmed
pubmed-article:20452314pubmed:issn1875-9777lld:pubmed
pubmed-article:20452314pubmed:authorpubmed-author:LöserPeterPlld:pubmed
pubmed-article:20452314pubmed:authorpubmed-author:LoringJeanne...lld:pubmed
pubmed-article:20452314pubmed:authorpubmed-author:MüllerFranz-J...lld:pubmed
pubmed-article:20452314pubmed:authorpubmed-author:GoldmannJohan...lld:pubmed
pubmed-article:20452314pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20452314pubmed:day7lld:pubmed
pubmed-article:20452314pubmed:volume6lld:pubmed
pubmed-article:20452314pubmed:ownerNLMlld:pubmed
pubmed-article:20452314pubmed:authorsCompleteYlld:pubmed
pubmed-article:20452314pubmed:pagination412-4lld:pubmed
pubmed-article:20452314pubmed:meshHeadingpubmed-meshheading:20452314...lld:pubmed
pubmed-article:20452314pubmed:meshHeadingpubmed-meshheading:20452314...lld:pubmed
pubmed-article:20452314pubmed:meshHeadingpubmed-meshheading:20452314...lld:pubmed
pubmed-article:20452314pubmed:meshHeadingpubmed-meshheading:20452314...lld:pubmed
pubmed-article:20452314pubmed:meshHeadingpubmed-meshheading:20452314...lld:pubmed
pubmed-article:20452314pubmed:meshHeadingpubmed-meshheading:20452314...lld:pubmed
pubmed-article:20452314pubmed:meshHeadingpubmed-meshheading:20452314...lld:pubmed
pubmed-article:20452314pubmed:meshHeadingpubmed-meshheading:20452314...lld:pubmed
pubmed-article:20452314pubmed:meshHeadingpubmed-meshheading:20452314...lld:pubmed
pubmed-article:20452314pubmed:meshHeadingpubmed-meshheading:20452314...lld:pubmed
pubmed-article:20452314pubmed:year2010lld:pubmed
pubmed-article:20452314pubmed:articleTitleA call to standardize teratoma assays used to define human pluripotent cell lines.lld:pubmed
pubmed-article:20452314pubmed:affiliationDepartment of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037, USA. fj.mueller@zip.kiel.delld:pubmed
pubmed-article:20452314pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20452314pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20452314pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed